Marie L G Attwood

10PUBLICATIONS
24CO-AUTHORS
Infant and child healthMedical infection agents (incl. prions)PharmacogenomicsToxicology (incl. clinical toxicology)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 11, 2026
Defining a target product profile for antimicrobials to treat severe paediatric bacterial enteric infections in low- and medium-income countries, caused by E. coli, Shigella, Salmonella and Campylobacter species.

|Jun 16, 2026
MexXY-OprM efflux pump mediates resistance to odilorhabdins in Pseudomonas aeruginosa.

|Mar 24, 2026
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions.

Sanne van den Berg, Marie Attwood, Pippa Griffin

|Dec 01, 2025
Bacteriophage pharmacodynamics studied in an in vitro pharmacokinetic model of infection.

M L G Attwood, Pippa Griffin, Patryk Smorowinski

|Jul 17, 2025
Development of antibacterial drug + bacteriophage combination assays.

Marie Attwood, Pippa Griffins, Alan Noel

|May 16, 2025
In vitro activity of NOSO-502, a novel-action antimicrobial, against clinical strains of Enterobacterales including MDR strains.

Marie L G Attwood, Alan Noel, Pippa Griffin

Pageof 2

Frequent Collaborators

3 joint publications

Shampa Das

2 joint publications

Joseph Meletiadis

2 joint publications

Sanne van den Berg

2 joint publications

Sebastiaan D T Sassen